Delivery Order SPE2DR25D6028-SPE2DR26FASLT
- Not listed
- The Defense Logistics Agency awarded a $8,259.00 delivery order to AmerisourceBergen Drug Corp for Pediarix 0.5 mL syringes on December 2, 2025, with completion scheduled for December 3, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Pediarix 0.5 ML syringes with a firm fixed price ceiling value of $3,649.76 and an ultimate completion date of November 4, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December...
- The Defense Logistics Agency awarded a delivery order valued at $8,738.19 to AmerisourceBergen Drug Corp for Pediarix 0.5 mL syringes on December 2, 2025, with a completion date of December 3, 2025. The award was made on a firm fixed price basis with no set-aside designation, and the place of performance is located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $2,442.56 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Pediarix 0.5 mL syringes. This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 3, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $12,618.30 to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Pediarix 0.5mL syringes (10-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 17, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $4,248.55 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Pediarix 0.5 mL syringes. This is a competitively awarded, firm fixed-price contract with no set-aside designation and an ultimate completion date of December 8, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $8,259.00 delivery order to AmerisourceBergen Drug Corp for Pediarix 0.5 ML syringes on November 6, 2025, with completion scheduled for November 7, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The contract involves no set-aside designation and specifies...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on December 9, 2025, for the supply of Pediarix 0.5 ML syringes with a ceiling value of $3,019.86. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion by December 10, 2025, and will be performed at the contractor's corporate office location in...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Pediarix 0.5 ML syringes, a pediatric vaccine product. This competitively awarded, non-set-aside contract is valued at $6,988.75 with a firm fixed price and an ultimate completion date of September 4, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Pediarix 0.5 ML syringes valued at $7,613.09. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of August 8, 2025, and represents a non-set-aside contract. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FASLTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Pediarix 0.5mL syringes (10-count packages) valued at $19,351.14 on December 8, 2025, with an ultimate completion date of December 9, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion and extending through December 2026. The product will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, supplies a comprehensive portfolio of medications and medical commodities to support military and veteran healthcare systems. This delivery order for Pediarix vaccine syringes exemplifies the company's role in fulfilling DLA's pharmaceutical and medical supply requirements across multiple therapeutic domains. As a prime vendor under the DLA's global pharmaceutical support program, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities, with the DLA planning to expand its Pharmaceutical Prime Vendor Global Program Generation V through multiple regional awards in coming years.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.4k | 12/7/25 |